instruction:
Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.
question:
His wife beat a more formidable challenger. Molly Crosby, a 32-year-old mother of five, had been dealing with bouts of coughing and congestion all summer. Some preliminary exams in Green Bay showed a spot on her right lung. That led the Crosbys to the Mayo Clinic in Rochester, Minn., for additional tests. A carcinoid endocrine tumor was found. The tumor isn't as dangerous as other forms of cancer but was disconcerting for an otherwise healthy, nonsmoker. "We found out the day before we reported to camp," Crosby said on Wednesday. "We were at Mayo the two or three days leading up to training camp, when they did all their scans and got the final prognosis." Crosby flew back to Green Bay for the start of training camp. After a subpar 2018 season, Crosby had to beat out Sam Ficken. Crosby managed to keep his focus and retained the job for a 13th season. "I've trained a long time in compartmentalizing different situations," Crosby said. "Whenever I was home, I was fully home. The organization was unbelievable through training camp, just giving me time to be with Molly and be with the family and help where I could throughout the day and evening. I just tried to be fully in on both things. I have felt a lot of freedom in this. "I love doing what I'm doing but the importance of taking care of family and being there for Molly and the kids, when I look back on it, it was a special camp. I was able to really fully immerse in both things. It was nerve-wracking, too. Day in and day out, it was coming in, having to work and compete at a high level, and then going home and flowing back into a normal routine. Then, we'd sit down at night and you'd remember that surgery was coming and Molly had cancer. Those things were heavy." That surgery was at the end of the preseason, with part of Molly's right lung removed. While she will go back to Mayo for a scan in mid-October, Crosby said the doctors are positive they got rid of the tumor and she will not require radiation or chemotherapy. Since 2009, the NFL has held its annual "Crucial Catch" campaign to raise money for the American Cancer Society. It was a campaign that had already hit home for Crosby. A grandmother died of breast cancer and a sister-in-law is in her third year battling ovarian cancer. Now with his wife's diagnosis, the fight against cancer has grown more meaningful. "That's what it's about is early detection," he said. "It's getting routine checkups. Don't take it for granted. The numbers, with our technology, are amazing with prevention but treating it if you catch it early enough. That's one of the big things is pushing that. Let's try to get earlier detection so we can fight this thing. "With Molly's cancer, it's always been really important to me but I'm going to continue to push the charge forward and make sure that everybody gets the care. We feel so fortunate with the care that we got. Hopefully, everybody gets the same care and the same prognosis that we got." The Packers (3-1) will play at the Dallas Cowboys (3-1) on Sunday. Some of Crosby's finest professional moments have happened at AT&T Stadium. In the 2010 season, the Packers won the Super Bowl in Arlington. A playoff game in the 2016 season against the Cowboys marked the highlight of his career. His 56-yard field goal with 1:33 to play gave the Packers a 31-28 lead. Dallas tied the score, but Crosby booted a 51-yarder on the final play for a 34-31 victory. "The two minutes in that game were the most exciting two minutes I think I've ever had in a game," he said. "To be able to execute it twice in that situation was awesome." ___ More AP NFL: https://apnews.com/NFL and https://twitter.com/AP_NFL
answer:
Wife's cancer diagnosis hits home for Packers' Crosby.

question:
There's no discussion of cost, even to mention that statins are relatively inexpensive these days and are mostly generically available. To its credit, the article does mention the cost of a calcium scan. We learn that "anywhere from 50 to 200 healthy people need to take a statin daily to prevent a single heart attack for five years." That's helpful information. It also notes that the observed benefit is less for older patients. The story could have added that even those numbers might disputed by some experts who perceive no meaningful benefit. For example, one review found being on a statin does not help people with low risk for heart disease live longer. The story does a service by highlighting the harms of statins. It explains: "The most common side effect of these drugs is muscle pain, which usually goes away if patients stop taking the medicines. People taking statins are also at a higher risk of developing diabetes, which is harder to reverse." It also mentions the potential for overtreatment with the use of coronary calcium scans. However, we wish it had included absolute numbers. The story says harms are "uncommon," but provides no data to back that up. Rates of adverse effects with statins have been measured at 1 to 10%, which makes them "common" in the definition of the European Medicines Agency. Also noteworthy is that some contend that adverse effects of statins have not been reliably reported. The story doesn't explain the quality of the study, or of studies on which current guidelines are based. We don't explicitly learn that this is a modelling study. In other words, this study consisted mostly of reinterpretations of math, not re-evaluations of real-life patients. The researchers said they were unable to obtain enough data on all possible harms and age-specific data on some harm outcomes, "so the risk thresholds we determined may still be too low." There is no disease-mongering here. This story includes sources that weren't involved in the study. The study's authors reported no conflicts of interest. The story could have acknowledged the influence of pharmaceutical companies in creating guidelines for statin use. The alternative of not taking a statin was the key message here, and that's laudable. However, we have a couple of concerns. First, we learn that "some statins were more effective than others, with atorvastatin (the generic name for Lipitor) being the best of the bunch." However, the story doesn't explain on what basis some statins are "more effective." In fact, some statins may be more effective at lower cholesterol, but the study found that no statin rises above others when it comes to the outcomes that counts most to patients reducing cardiovascular deaths. Also, the story doesn't mention lifestyle interventions diet and exercise. The story makes it clear that statins are widely prescribed. The story states this an attempt to better weigh the benefits and harms of statin use. There was a good range of interviewees with no reliance on a news release
answer:
Before Starting A Statin, Talk It Over With Your Doctor

question:
The research, described as game-changing by experts in the field, suggests human cells could in future be reprogrammed by the same technique, offering a simpler way to replace damaged cells or grow new organs for sick and injured people. Chris Mason, chair of regenerative medicine bioprocessing at University College London, who was not involved in the work, said its approach in mice was "the most simple, lowest-cost and quickest method" to generate so-called pluripotent cells - able to develop into many different cell types - from mature cells. "If it works in man, this could be the game changer that ultimately makes a wide range of cell therapies available using the patient's own cells as starting material - the age of personalized medicine would have finally arrived," he said. The experiments, reported in two papers in the journal Nature on Wednesday, involved scientists from the RIKEN Center for Developmental Biology in Japan and Brigham and Women's Hospital and Harvard Medical School in the United States. The researchers took skin and blood cells, let them multiply, then subjected them to stress "almost to the point of death", they explained, by exposing them to various events including trauma, low oxygen levels and acidic environments. One of these "stressful" situations was simply to bathe the cells in a weak acid solution for around 30 minutes. Within days, the scientists found that the cells had not only survived but had also recovered by naturally reverting into a state similar to that of an embryonic stem cell. These stem cells - dubbed Stimulus-Triggered Acquisition of Pluripotency, or STAP, cells by the researchers - were then able to differentiate and mature into different types of cells and tissue, depending on the environments they were put in. "If we can work out the mechanisms by which differentiation states are maintained and lost, it could open up a wide range of possibilities for new research and applications using living cells," said Haruko Obokata, who lead the work at RIKEN. Stem cells are the body's master cells and are able to differentiate into all other types of cells. Scientists say that by helping to regenerate tissue and potentially grow new organs, they could offer ways of tackling diseases for which there are currently only limited treatments. Recent experimental research has seen stem cells used to create a functional human liver and to create beating heart muscle tissue. There are two main types of stem cells: embryonic ones, harvested from embryos, and adult or iPS cells, which are taken from skin or blood and reprogrammed back into stem cells. Because the harvesting of embryonic stem cells requires the destruction of a human embryo, the technique has been the subject of ethical concerns and protests from pro-life campaigners. Dusko Ilic, a reader in stem cell science at Kings College London, said the Nature studies described "a major scientific discovery" and predicted their findings would open "a new era in stem cell biology". "Whether human cells would respond in a similar way to comparable environmental cues ... remains to be shown," he said in an emailed comment. "I am sure that the group is working on this and I would not be surprised if they succeed even within this calendar year." Robin Lovell-Badge, a stem cell expert at Britain's National Institute for Medical Research, said it would be some time before the exact nature and capabilities of the STAP cells would be fully understood by scientists - and only then would their full potential in medicine become clearer. "But the really intriguing thing to discover will be the mechanism underlying how a low pH shock triggers reprogramming," he said. "And why does it not happen when we eat lemon or vinegar, or drink cola?"
answer:
Scientists hail breakthrough in embryonic-like stem cells.